<DOC>
	<DOCNO>NCT03069131</DOCNO>
	<brief_summary>We wish perform multicenter , double-blind RCT two parallel-group stratify center , compare rifaximin rifaximin ( placebo ) primary prophylaxis SBP 'severe ' cirrhotic patient large ascites . The primary outcome 12-month survival .</brief_summary>
	<brief_title>Two Strategies Primary Prophylaxis Spontaneous Bacterial Peritonitis Severe Cirrhotic Patients With Ascites</brief_title>
	<detailed_description />
	<mesh_term>Ascites</mesh_term>
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>Cirrhosis diagnose clinical , radiological and/or histological finding Patients large ascites ( i.e. , grade 3 ascites require paracentesis ) . Ascites low protein level ascitic fluid ( &lt; 15 g/L ) : 1. impaired renal function define serum creatinine ≥ 106 mmol/L , uremia ≥ 9 mmol/L serum sodium ≤ 130 mmol/L ) , 2. severe liver impairment define ChildPugh score ≥ 9 serum total bilirubin level ≥ 51 mmol/L . Patient sign informed consent form Patient social security system Pregnant woman breastfeed Person 18 year age 80 year age Transplanted patient , HIV infection ( patient deny HIV serology ) immunosuppressive therapy Past SBP present bacterial infection Patient TIPS Patient receive antibiotic ( include rifaximin ) month precede inclusion study Hypersensitivity rifaximin , derivatives rifamycin one constituent preparation Hepatocellular carcinoma outside Milan criterion , cancer palliative stage , Gastrointestinal bleeding within 7 day Grade 3 hepatic encephalopathy ( HE ) screen phase randomization previous grade 3 HE Chronic heart failure ( stage III IV New York Heart Association [ NYHA ] Functional Classification Patient judge noncompliant Patients receive clear information trust relative Patient refuse participation agreement sign information form consent define protocol . Exclusion period another biomedical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>primary prophylaxis</keyword>
	<keyword>rifaximin</keyword>
</DOC>